Coronary Artery Disease Clinical Trials

A listing of Coronary Artery Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1265 clinical trials
featured
Sternal Cerclage (sternal bone closure after open heart surgery)

The purpose of the study is to learn which treatment option is better for patients who have multi-vessel coronary artery disease (blockages in more than one vessel supplying blood to the heart

coronary revascularization
acute coronary syndrome
revascularisation
  • 1160 views
  • 05 Feb, 2021
  • 1 location
featured
Inflammatory Characterization of Known or Possible Cardiovascular Diseases

Background: Cardiometabolic diseases are a combination of medical disorders that, when they occur together, increase the risk of heart disease and diabetes. Researchers want to learn if there is a relationship between these diseases and inflammation (redness, swelling, and pain). Inflammation affects the entire body. Researchers will study this relationship …

diabetes
heart disease
fats
  • 46 views
  • 23 Nov, 2020
  • 1 location
featured
CT COMPARE: CT COronary Angiography to Measure PlAque REduction

The study is investigating how the amount of plaque in your arteries can be reduced by statin medication. Researchers at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland, are looking for volunteers to participate in a 36-month study. There are no costs for study-related tests, procedures or medication. For …

hyperlipidemia
hmg-coa reductase inhibitors
statin therapy
  • 128 views
  • 22 Dec, 2020
  • 1 location
featured
Seeking Oklahomans with Diabetes who also have Coronary Artery Disease.

Seeking Oklahomans with Diabetes who also have Coronary Artery Disease.

  • 74 views
  • 08 Nov, 2020
  • 1 location
featured
Study for patients with stable heart failure of ischemic origin

We are carrying out a clinical trial with an investigational drug that is being developed with the intention of treating patients with heart failure of ischemic origin (heart failure characterised by a reduced blood supply to the heart). The main purpose of the study will be to assess how safe …

  • 89 views
  • 23 Nov, 2020
  • 1 location
featured
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.

TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.

  • 144 views
  • 08 Nov, 2020
  • 1 location
featured
Type 2 Diabetes with Cardiovascular Disease

Research study for those with Type 2 Diabetes AND Cardiovascular Disease.

  • 0 views
  • 08 Mar, 2021
  • 1 location
featured
Seeking Oklahomans who have been diagnosed with chronic or unstable angina.

Seeking Oklahomans who have been diagnosed with chronic or unstable angina.

  • 256 views
  • 08 Nov, 2020
  • 1 location
featured
Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the EfficaCy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, Oral b.i.d.) Versus Acetylsalicylic Acid (100 mg Oral q.d.) in Patients With Embolic Stroke of Undetermined Source (RESPECT ESUS)

Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the EfficaCy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, Oral b.i.d.) Versus Acetylsalicylic Acid (100 mg Oral q.d.) in Patients With Embolic Stroke of Undetermined Source (RESPECT ESUS)

  • 76 views
  • 25 Mar, 2021
  • 1 location
featured
ABSORB III - A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions Absorb™ is an investigational bioabsorbable vascular scaffold manufactured by Abbott. Absorb™ is referred to as a scaffold to indicate that it is a temporary structure.

ABSORB III - A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions Absorb™ is an investigational bioabsorbable vascular scaffold manufactured by Abbott. Absorb™ is referred to as a scaffold to indicate that it is a …

  • 120 views
  • 25 Mar, 2021
  • 1 location